Impact of diabetes mellitus on arterial stiffness in a representative sample of an urban Brazilian population

Diabetology and Metabolic Syndrome

Volumn 5, Issue 1, 2013, Pages

  De Oliveira Alvim, Rafael ^a   Santos, Paulo Caleb Junior Lima ^a   Musso, Mariane Manso ^b   De Sá Cunha, Roberto ^c   Krieger, José Eduardo ^a   Mill, José Geraldo ^c   Pereira, Alexandre Costa ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^c FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

Arterial stiffness; Brazilian population; Diabetes mellitus; Hypertension

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AMERICAN INDIAN; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; BRAZIL; CHOLESTEROL BLOOD LEVEL; COMMUNITY SAMPLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE COURSE; EUROPEAN AMERICAN; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULATTO; PRIORITY JOURNAL; PULSE WAVE; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URBAN POPULATION;

EID: 84883243531     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-5-45     Document Type: Article

References (50)

1. Arterial stiffness: a new cardiovascular risk factor? Arnett DK, Evans GW, Riley WA, Am J Epidemiol 1994 140 8 669 682 7942769
2. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Meaume S, Benetos A, Henry OF, Rudnichi A, Safar ME, Arterioscler Thromb Vasc Biol 2001 21 12 2046 2050 10.1161/hq1201.100226 11742883
3. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A, Hypertension 2001 37 5 1236 1241 10.1161/01.HYP.37.5.1236 11358934
4. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Laurent S, Katsahian S, Fassot C, Tropeano AI, Gautier I, Laloux B, Boutouyrie P, Stroke 2003 34 5 1203 1206 10.1161/01.STR.0000065428.03209.64 12677025
5. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, Asmar R, Reneman RS, Hoeks AP, Breteler MM, et al. Circulation 2006 113 5 657 663 10.1161/CIRCULATIONAHA.105.555235 16461838
6. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. Vlachopoulos C, Aznaouridis K, Stefanadis C, J Am Coll Cardiol 2010 55 13 1318 1327 10.1016/j.jacc.2009.10. 061 20338492
7. Arterial stiffness and cardiovascular outcome. Zoungas S, Asmar RP, Clin Exp Pharmacol Physiol 2007 34 7 647 651 10.1111/j.1440-1681.2007.04654.x 17581224
8. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Vaitkevicius PV, Fleg JL, Engel JH, O'Connor FC, Wright JG, Lakatta LE, Yin FC, Lakatta EG, Circulation 1993 88 4 Pt 1 1456 1462 8403292
9. Acute reduction of blood pressure by nitroglycerin does not normalize large artery stiffness in essential hypertension. Stewart AD, Jiang B, Millasseau SC, Ritter JM, Chowienczyk PJ, Hypertension 2006 48 3 404 410 10.1161/01.HYP.0000237669.64066.c5 16908758
10. Arterial distensibility in adolescents: the influence of adiposity, the metabolic syndrome, and classic risk factors. Whincup PH, Gilg JA, Donald AE, Katterhorn M, Oliver C, Cook DG, Deanfield JE, Circulation 2005 112 12 1789 1797 10.1161/CIRCULATIONAHA.104.532663 16172286
11. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM, Circulation 2001 103 7 987 992 10.1161/01.CIR.103.7.987 11181474
12. Sex differences in age-related stiffening of the aorta in subjects with type 2 diabetes. De Angelis L, Millasseau SC, Smith A, Viberti G, Jones RH, Ritter JM, Chowienczyk PJ, Hypertension 2004 44 1 67 71 10.1161/01.HYP. 0000130482.81883.fd 15148292
13. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Stehouwer CD, Henry RM, Ferreira I, Diabetologia 2008 51 4 527 539 10.1007/s00125-007-0918-3 18239908
14. Stehouwer CD, Diabetes, Lipids and Other Risk Factors London: Elsevier 2006
15. Glucose, insulin, diabetes and mechanisms of arterial dysfunction. Cameron JD, Cruickshank JK, Clin Exp Pharmacol Physiol 2007 34 7 677 682 10.1111/j.1440-1681.2007.04659.x 17581229
16. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Creager MA, Luscher TF, Cosentino F, Beckman JA, Circulation 2003 108 12 1527 1532 10.1161/01.CIR.0000091257.27563.32 14504252
17. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A, Circulation 1994 90 1 583 612 10.1161/01.CIR.90.1.583 8026046
18. APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population. Alvim RO, Freitas SR, Ferreira NE, Santos PC, Cunha RS, Mill JG, Krieger JE, Pereira AC, Lipids Health Dis 2010 9 128 10.1186/1476-511X-9-128 21059196
19. Fonseca J: [Race, compliance to treatment and/or consultation and control of arterial hypertension]. Lessa I, Arq Bras Cardiol 1997 68 6 443 449 9515252
20. Endothelial nitric oxide synthase gene variant modulates the relationship between serum cholesterol levels and blood pressure in the general population: new evidence for a direct effect of lipids in arterial blood pressure. Pereira AC, Sposito AC, Mota GF, Cunha RS, Herkenhoff FL, Mill JG, Krieger JE, Atherosclerosis 2006 184 1 193 200 10.1016/j.atherosclerosis.2005.03.035 15916766
21. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001 285 19 2486 2497 10.1001/jama.285.19.2486 11368702
22. MYLIP p.N342S polymorphism is not associated with lipid profile in the Brazilian population. Santos PC, Oliveira TG, Lemos PA, Mill JG, Krieger JE, Pereira AC, Lipids Health Dis 2012 11 83 10.1186/1476-511X-11-83 22741812
23. Ethnicity and arterial stiffness in Brazil. Santos PC, Alvim Rde O, Ferreira NE, de Sa CR, Krieger JE, Mill JG, Pereira AC, Am J Hypertens 2011 24 3 278 284 10.1038/ajh.2010.244 21183929
24. - 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999 17 2 151 183 10067786
25. - 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, et al. J Hypertens 2007 25 6 1105 1187 10.1097/HJH.0b013e3281fc975a 17563527
26. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, Target R, Levy BI, Hypertension 1995 26 3 485 490 10.1161/01.HYP.26.3.485 7649586
27. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M, N Engl J Med 1998 339 4 229 234 10.1056/NEJM199807233390404 9673301
28. Increased arterial stiffness in subjects with impaired glucose tolerance and newly diagnosed diabetes but not isolated impaired fasting glucose. Li CH, Wu JS, Yang YC, Shih CC, Lu FH, Chang CJ, J Clin Endocrinol Metab 2012 97 4 658 662 10.1210/jc.2011-2595 22337914
29. Increased arterial stiffness in children and adolescents with type 1 diabetes: no association between arterial stiffness and serum levels of adiponectin. Galler A, Heitmann A, Siekmeyer W, Gelbrich G, Kapellen T, Kratzsch J, Kiess W, Pediatr Diabetes 2010 11 1 38 46 10.1111/j.1399-5448.2009.00525.x 19496970
30. Association of arterial stiffness with HbA1c in 1,000 type 2 diabetic patients with or without hypertension. Chen Y, Huang Y, Li X, Xu M, Bi Y, Zhang Y, Gu W, Ning G, Endocrine 2009 36 2 262 267 10.1007/s12020-009-9221-z 19598004
31. Increasing derangement of glucose homeostasis is associated with increased arterial stiffness in patients with diabetes, impaired fasting glucose and normal controls. Lukich E, Matas Z, Boaz M, Shargorodsky M, Diabetes Metab Res Rev 2010 26 5 365 370 10.1002/dmrr.1086 20568265
32. Early adverse effect of abnormal glucose metabolism on arterial stiffness in drug naive hypertensive patients. Vyssoulis G, Pietri P, Vlachopoulos C, Alexopoulos N, Kyvelou SM, Terentes-Printzios D, Stefanadis C, Diab Vasc Dis Res 2012 9 1 18 24 10.1177/1479164111422827 21994165
33. Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus. Yue WS, Lau KK, Siu CW, Wang M, Yan GH, Yiu KH, Tse HF, Cardiovasc Diabetol 2011 10 113 10.1186/1475-2840-10-113 22185563
34. Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Mazzone T, Chait A, Plutzky J, Lancet 2008 371 9626 1800 1809 10.1016/S0140-6736(08)60768-0 18502305
35. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. Aronson D, J Hypertens 2003 21 1 3 12 10.1097/00004872-200301000-00002 12544424
36. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, Andrews JW, Hayes JR, Diabetologia 1992 35 8 771 776 1511805
37. Determinants of vascular function in patients with type 2 diabetes. Naka KK, Papathanassiou K, Bechlioulis A, Kazakos N, Pappas K, Tigas S, Makriyiannis D, Tsatsoulis A, Michalis LK, Cardiovasc Diabetol 2012 11 127 10.1186/1475-2840-11-127 23062182
38. Advanced glycation end products and endothelial dysfunction in type 2 diabetes. Tan KC, Chow WS, Ai VH, Metz C, Bucala R, Lam KS, Diabetes Care 2002 25 6 1055 1059 10.2337/diacare.25.6.1055 12032114
39. Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia. Watts GF, O'Brien SF, Silvester W, Millar JA, Clin Sci (Lond) 1996 91 5 567 573
40. Diabetes and hypertension: the bad companions. Ferrannini E, Cushman WC, Lancet 2012 380 9841 601 610 10.1016/S0140-6736(12)60987-8 22883509
41. Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure. Chen G, McAlister FA, Walker RL, Hemmelgarn BR, Campbell NR, Hypertension 2011 57 5 891 897 10.1161/HYPERTENSIONAHA.110.162446 21403089
42. Microvascular degenerative complications are associated with increased aortic stiffness in type 2 diabetic patients. Cardoso CR, Ferreira MT, Leite NC, Barros PN, Conte PH, Salles GF, Atherosclerosis 2009 205 2 472 476 10.1016/j.atherosclerosis.2008.12.027 19185301
43. Effects of coexisting hypertension and type II diabetes mellitus on arterial stiffness. Tedesco MA, Natale F, Di Salvo G, Caputo S, Capasso M, Calabro R, J Hum Hypertens 2004 18 7 469 473 10.1038/sj.jhh.1001690 14985776
44. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D, Hypertension 1995 25 3 305 313 10.1161/01.HYP.25.3.305 7875754
45. Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. The Framingham Heart Study 1950 to 1990. Sytkowski PA, D'Agostino RB, Belanger AJ, Kannel WB, Circulation 1996 93 4 697 703 10.1161/01.CIR.93.4.697 8640998
46. Racial differences in aortic stiffness in normotensive and hypertensive adults. Ferreira AV, Viana MC, Mill JG, Asmar RG, Cunha RS, J Hypertens 1999 17 5 631 637 10.1097/00004872-199917050-00006 10403606
47. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, Brown C, Roccella EJ, Hypertension 1995 26 1 60 69 10.1161/01.HYP.26.1.60 7607734
48. Race and sex differentials in the impact of hypertension in the United States. The National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Cornoni-Huntley J, LaCroix AZ, Havlik RJ, Arch Intern Med 1989 149 4 780 788 10.1001/archinte.1989.00390040022005 2784957
49. Increased arterial stiffness in Europeans and African Caribbeans with type 2 diabetes cannot be accounted for by conventional cardiovascular risk factors. Strain WD, Chaturvedi N, Dockery F, Shiff R, Shore AC, Bulpitt CJ, Rajkumar C, Am J Hypertens 2006 19 9 889 896 10.1016/j.amjhyper.2006.01.009 16942929
50. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, Filipovsky J, Huybrechts S, Mattace-Raso FU, Protogerou AD, et al. J Hypertens 2012 30 3 445 448 10.1097/HJH.0b013e32834fa8b0 22278144